ChemKart India shares jump on making strategic investment ₹2 Cr in Easy Raw MaterialsChemKart India shares jump on making strategic investment ₹2 Cr in Easy Raw Materials

Introduction

Leading Indian nutraceuticals firm invests Rs. 2 Crores in its wholly owned subsidiary through a Rights Issue to expand production of health supplements.

Also Read: Enviro Infra Engineers rallies 11.5% after securing Aurangabad STP project under AMRUT 2.0

Share price movement of ChemKart India

On March 13, 2026, ChemKart India Ltd opened at ₹110.00, up 2.64% from its previous close of ₹107.25. The stock reached a high of ₹110.00 (2.64%) and a low of ₹107.02. By 12:03 PM, it traded at ₹108.00, a 0.70% increase, with a market cap of ₹130.67 crore.

ChemKart Invests in Subsidiary

ChemKart India Ltd has invested Rs. 2.00 Crores in Easy Raw Materials Pvt Ltd. The investment was through a Rights Issue of 20,00,000 equity shares at Rs. 10 each.

Easy Raw Materials Pvt Ltd, incorporated in 2020, is engaged in manufacturing nutraceuticals and health supplements. The subsidiary’s turnover for the last three years has been NIL, with a net loss of Rs. 12.68 lakhs.

The transaction is a related party deal, executed at arm’s length. Post-allotment, ChemKart holds 100% of the subsidiary. The investment is for commissioning the subsidiary’s manufacturing unit.

Stock performance of ChemKart India for period of 1 week, 1 month, and 6 months

ChemKart India Ltd delivered a 3.12% return over the past week, declined 1.52% over the past month, and dropped 47.9% in the past 6 months.

Also Read: Wanbury Ltd strengthens Brazil dominance with Sertraline Form II approval, here’s what it means

Shareholding pattern of ChemKart India

Particulars	Sep 2025	Jul 2025
Promoter	73.30%	73%
FII	1.00%	1.80%
DII	6.80%	9.10%
Public	19.00%	15.80%

About ChemKart India

ChemKart India Ltd (BSE: 544442), incorporated in 2020 and based in Mumbai, is a B2B distributor and processor of nutraceutical ingredients.

Stay Ahead with the Latest Stock Market Updates – Click Here

Disclaimer: The above article is written for educational purposes, and the companies’ data mentioned in the article may change with respect to time. The securities quoted are exemplary and are not recommendatory.

FAQs